Product NDC: | 49349-757 |
Proprietary Name: | CELESTONE SOLUSPAN |
Non Proprietary Name: | Betamethasone Acetate and Betamethasone Sodium Phosphate |
Active Ingredient(s): | 3; 3 mg/mL; mg/mL & nbsp; Betamethasone Acetate and Betamethasone Sodium Phosphate |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION, SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49349-757 |
Labeler Name: | REMEDYREPACK INC. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA014602 |
Marketing Category: | NDA |
Start Marketing Date: | 20130610 |
Package NDC: | 49349-757-01 |
Package Description: | 5 mL in 1 VIAL (49349-757-01) |
NDC Code | 49349-757-01 |
Proprietary Name | CELESTONE SOLUSPAN |
Package Description | 5 mL in 1 VIAL (49349-757-01) |
Product NDC | 49349-757 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Betamethasone Acetate and Betamethasone Sodium Phosphate |
Dosage Form Name | INJECTION, SUSPENSION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 20130610 |
Marketing Category Name | NDA |
Labeler Name | REMEDYREPACK INC. |
Substance Name | BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE |
Strength Number | 3; 3 |
Strength Unit | mg/mL; mg/mL |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |